These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 6140853)

  • 1. Evidence of a paracrine role for pancreatic somatostatin in vivo.
    Taborsky GJ
    Am J Physiol; 1983 Dec; 245(6):E598-603. PubMed ID: 6140853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic somatostatin is a mediator of glucagon inhibition by hyperglycemia.
    Klaff LJ; Taborsky GJ
    Diabetes; 1987 May; 36(5):592-6. PubMed ID: 2883057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous hyperglycemia restores insulin release impaired by somatostatin analogue.
    Taborsky GJ; Porte D
    Am J Physiol; 1981 Apr; 240(4):E407-13. PubMed ID: 6111928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of somatostatin analogues on alpha- and beta-cells of the pancreas.
    Taborsky GJ; Smith PH; Porte D
    Am J Physiol; 1979 Feb; 236(2):E123-8. PubMed ID: 369388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin-28 does not regulate islet function in the dog.
    Klaff LJ; Dunning BE; Taborsky GJ
    Endocrinology; 1988 Dec; 123(6):2668-74. PubMed ID: 2904358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
    Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
    Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of pancreatic somatostatin in determining glucagon response to arginine and morphine.
    Klaff LJ; Taborsky GJ
    Am J Physiol; 1987 Jun; 252(6 Pt 1):E751-5. PubMed ID: 2884887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infusion of graded concentrations of somatostatin in man: pharmacokinetics and differential inhibitory effects on pituitary and islet hormones.
    Skamene A; Patel YC
    Clin Endocrinol (Oxf); 1984 May; 20(5):555-64. PubMed ID: 6146413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of phentolamine on the somatostatin-induced inhibition of glucagon and insulin secretion.
    Kaneto A; Kajinuma H; Kaneko T; Kosaka K
    Metabolism; 1978 Aug; 27(8):901-10. PubMed ID: 209286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonadrenergic sympathetic neural influences on basal pancreatic hormone secretion.
    Dunning BE; Ahrén B; Veith RC; Taborsky GJ
    Am J Physiol; 1988 Dec; 255(6 Pt 1):E785-92. PubMed ID: 2904765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vivo model for testing inhibition of arginine-induced insulin and glucagon release by somatostatin analogs.
    Gordin A; Meyers C; Arimura A; Coy DH; Schally AV
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):833-41. PubMed ID: 335762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release.
    Karashima T; Cai RZ; Schally AV
    Life Sci; 1987 Aug; 41(8):1011-9. PubMed ID: 2886886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central factors in the control of insulin and glucagon secretion.
    Porte D; Woods SC; Chen M; Smith PH; Ensinck JW
    Pharmacol Biochem Behav; 1975; 3(1 Suppl):127-33. PubMed ID: 775499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pancreatic noradrenaline infusion on basal and stimulated islet hormone secretion in the dog.
    Ahrén B; Taborsky GJ
    Acta Physiol Scand; 1988 Feb; 132(2):143-50. PubMed ID: 2906499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin analogs inhibit somatostatin release.
    Ipp E; Rivier J; Dobbs RE; Brown M; Vale W; Unger RH
    Endocrinology; 1979 May; 104(5):1270-3. PubMed ID: 436775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo stimulation of pancreatic hormone secretion by norepinephrine infusion in the dog.
    Ribes G; Trimble ER; Blayac JP; Wollheim CB; Loubatières-Mariani MM
    Am J Physiol; 1984 Apr; 246(4 Pt 1):E339-43. PubMed ID: 6144271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Action of [3,14-L-selenocysteine, 8-D-tryptophan]-somatostatin on insulin and glucagon secretion of the isolated perfused pancrease of the Wistar rat].
    Bierwolf B; Hartrodt B; Neubert R; Jakubke HD; Blech W
    Biomed Biochim Acta; 1986; 45(5):611-8. PubMed ID: 2875714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 1). Effects on basal release of insulin and glucagon.
    Ahrén B; Veith RC; Taborsky GJ
    Endocrinology; 1987 Jul; 121(1):323-31. PubMed ID: 3297643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-selective inhibition of basal glucagon release by [D-Cys14]-analogues of somatostatin in the rat.
    Märki F; Kamber B; Rink H; Sieber P
    J Endocrinol; 1979 Jun; 81(3):315-23. PubMed ID: 469462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for autonomic nervous system to increase pancreatic glucagon secretion during marked insulin-induced hypoglycemia in dogs.
    Havel PJ; Veith RC; Dunning BE; Taborsky GJ
    Diabetes; 1991 Sep; 40(9):1107-14. PubMed ID: 1682196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.